Product Information

ALLOPURINOL 100 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.0322 per EA under NDC 69315029105. Its NADAC has been published 159 times since Nov 8, 2023.

FDA first approved this application on Mar 7, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ALLOPURINOL 100 MG TABLET

Allopurinol
$0.0322per EA
High Outlier

Strength

100 mg/1

NDC

69315029105

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ALLOPURINOL

Approval Type

Generic (ANDA)

FDA Application

ANDA214443

FDA Approved

3/7/2022

TE Code

AB

On Market Since

5/1/2024

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for ALLOPURINOL 100 MG TABLET has been published 159 times since Nov 8, 2023, and over the history we have for it it has declined 34.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0322 per EA
All-time high$0.0513 (Jan 10, 2024)
All-time low$0.0312 (Oct 21, 2026)
52-week high$0.0366
52-week low$0.0312
Median price$0.0396
Average price$0.0401
Largest weekly change-28.6% (Nov 20, 2024)
Weeks tracked159
Tracking sinceNov 8, 2023

Price History

1W

+3.1%

1M

+3.1%

3M

+1.5%

6M

-3.6%

1Y

-11.9%

3Y

-34.7%

5Y

N/A

All

-34.7%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ALLOPURINOL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 100 MG TABLET, manufactured by Leading Pharma, LLC, is $0.0322 per EA (NDC 69315029105), effective Nov 18, 2026.

How has the price of ALLOPURINOL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALLOPURINOL 100 MG TABLET has declined 34.7%. It has been tracked across 159 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for ALLOPURINOL 100 MG TABLET?

Since Nov 8, 2023, the NADAC for ALLOPURINOL 100 MG TABLET has ranged from a low of $0.0312 (Oct 21, 2026) to a high of $0.0513 (Jan 10, 2024), with a median of $0.0396 per EA.

Are there cheaper alternatives to ALLOPURINOL 100 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALLOPURINOL 100 MG TABLET, is $0.0317 per EA — about 1% below ALLOPURINOL 100 MG TABLET.

Who manufactures ALLOPURINOL 100 MG TABLET?

ALLOPURINOL 100 MG TABLET (NDC 69315029105) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.